Asian-American Women and Osteoporosis
What Treatments Are Available?
Although there is no cure for osteoporosis, there are
treatments available to help stop further bone loss and reduce the risk of
- Alendronate (Fosamax1), risedronate (Actonel), and ibandronate
(Boniva) are bisphosphonates approved for preventing and treating
postmenopausal osteoporosis. Alendronate is also approved for treating
osteoporosis in men and for use by men and women with glucocorticoid-induced
osteoporosis. In addition, risedronate is approved for preventing and treating
glucocorticoid-induced osteoporosis in both women and men. Alendronate plus
vitamin D (Fosamax Plus D) is available for treating osteoporosis in
postmenopausal women and in men. Risedronate with calcium (Actonel with
Calcium) is available for preventing and treating osteoporosis in
- Calcitonin (Miacalcin) is another treatment used by women for
- Raloxifene (Evista), a Selective Estrogen Receptor Modulator, is approved
for preventing and treating postmenopausal osteoporosis.
- Teriparatide (Forteo) is an injectable form of human parathyroid hormone
(PTH). It is approved for postmenopausal women and men with osteoporosis who
are at high risk for having a fracture.
- Estrogen therapy (also called hormone therapy when estrogen and another
hormone, progestin, are combined) is approved for preventing postmenopausal
osteoporosis. It should only be considered for women at significant risk of
osteoporosis after nonestrogen medications have been carefully considered.
|1 Brand names included in this publication are
provided as examples only, and their inclusion does not mean that these
products are endorsed by the National Institutes of Health or any other
Government agency. Also, if a particular brand name is not mentioned, this does
not mean or imply that the product is unsatisfactory.|